Related Experiment Video
Updated: Sep 30, 2025

07:01
An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
Published on: April 17, 2013
21.2K
Mislocalization of Cancer-associated Thyroid Hormone Receptor Mutants.
Michael S Salomon1, S Harshini Malapati1, Jerry O' Dwyer1
1Department of Biology, William & Mary, 540 Landrum Drive, ISC 3035, Williamsburg, VA, 23185, USA.
Summary
Cancer-associated mutations disrupt thyroid hormone receptor (TR) localization, causing it to accumulate in the cytoplasm and form aggregates, impacting gene regulation and disease development.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Thyroid hormone receptor (TR) regulates metabolism and development by controlling gene expression.
- TR nuclear transport, mediated by nuclear localization signals (NLSs) and nuclear export signals (NESs), is crucial for its function.
- Altered TR localization is linked to various diseases.
Purpose of the Study:
- To investigate the impact of cancer-associated mutations on TRα1 localization.
- To analyze structural components of TR affected by these mutations.
- To explore the link between TR trafficking, misfolding, and cancer.
Main Methods:
- Mammalian cell transfection with GFP and mCherry-tagged TRα1 mutants.
- Quantitative fluorescence microscopy to analyze TRα1 localization.
- In silico modeling to assess structural alterations in TRα1 mutants.
Main Results:
- Cancer-associated TRα1 mutations significantly alter protein localization patterns.
- Many mutants exhibit a shift towards increased cytoplasmic localization.
- Mutant TRα1 proteins show a propensity to form cytosolic and nuclear aggregates.
Conclusions:
- Cancer-associated mutations disrupt normal TRα1 trafficking and localization.
- Misfolding and aggregation of TRα1 may contribute to disease pathogenesis.
- TRα1 localization is a critical factor in maintaining cellular homeostasis and preventing disease.
Related Concept Videos
Targeted Cancer Therapies
7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.9K
Receptor Downregulation in MVBs
2.2K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.2K
Synthesis and Regulation of Thyroid Hormones
5.3K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
5.3K
Mitogens and the Cell Cycle
7.0K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K

